192 related articles for article (PubMed ID: 21626506)
1. Risk of metachronous contralateral testicular germ cell tumors: a population-based study of 7,102 Norwegian patients (1953-2007).
Andreassen KE; Grotmol T; Cvancarova MS; Johannesen TB; Fosså SD
Int J Cancer; 2011 Dec; 129(12):2867-74. PubMed ID: 21626506
[TBL] [Abstract][Full Text] [Related]
2. Risk and prognostic significance of metachronous contralateral testicular germ cell tumours.
Schaapveld M; van den Belt-Dusebout AW; Gietema JA; de Wit R; Horenblas S; Witjes JA; Hoekstra HJ; Kiemeney LA; Louwman WJ; Ouwens GM; Aleman BM; van Leeuwen FE
Br J Cancer; 2012 Oct; 107(9):1637-43. PubMed ID: 23059747
[TBL] [Abstract][Full Text] [Related]
3. Dose-Dependent Effect of Platinum-Based Chemotherapy on the Risk of Metachronous Contralateral Testicular Cancer.
Blok JM; Groot HJ; Huele EH; de Wit R; Horenblas S; Nuver J; Groenewegen G; Bosch JLHR; Witjes JA; Tromp JM; de Brouwer PJM; van den Berg HA; Vanneste BGL; Smilde TJ; Aarts MJB; Gietema JA; Meijer RP; Schaapveld M
J Clin Oncol; 2021 Feb; 39(4):319-327. PubMed ID: 33119475
[TBL] [Abstract][Full Text] [Related]
4. Metachronous Contralateral Testicular Cancer in the Cisplatin Era: A Population-Based Cohort Study.
Hellesnes R; Myklebust TÅ; Bremnes RM; Karlsdottir Á; Kvammen Ø; Negaard HFS; Tandstad T; Wilsgaard T; Fosså SD; Haugnes HS
J Clin Oncol; 2021 Feb; 39(4):308-318. PubMed ID: 33356420
[TBL] [Abstract][Full Text] [Related]
5. Bilateral testicular germ cell tumors in patients treated for clinical stage I non-seminoma within two risk-adapted SWENOTECA protocols.
Tandstad T; Solberg A; Håkansson U; Stahl O; Haugnes HS; Oldenburg J; Dahl O; Kjellman A; Angelsen A; Cohn-Cedermark G;
Acta Oncol; 2015 Apr; 54(4):493-9. PubMed ID: 25192551
[TBL] [Abstract][Full Text] [Related]
6. Incidence and clinical pattern of contralateral synchronous and metachronous germ cell testicular cancer.
Maroto P; García Del Muro X; Valverde C; Pinto A; Sanchez A; Guma J; Alonso T; Martínez Del Prado P; Vazquez S; Mellado B; Aparicio J; Fernandez-Aramburo A; Girones R; Terrasa J;
Urol Oncol; 2021 Feb; 39(2):135.e17-135.e23. PubMed ID: 33189529
[TBL] [Abstract][Full Text] [Related]
7. Risk of contralateral testicular cancer: a population-based study of 29,515 U.S. men.
Fosså SD; Chen J; Schonfeld SJ; McGlynn KA; McMaster ML; Gail MH; Travis LB
J Natl Cancer Inst; 2005 Jul; 97(14):1056-66. PubMed ID: 16030303
[TBL] [Abstract][Full Text] [Related]
8. Optimized detection of germ cell neoplasia in situ in contralateral biopsy reduces the risk of second testis cancer.
Rajpert-De Meyts E; Jørgensen N; Petersen JH; Almstrup K; Aksglaede L; Lauritsen J; Rørth M; Daugaard G; Skakkebaek NE
BJU Int; 2022 Nov; 130(5):646-654. PubMed ID: 35575005
[TBL] [Abstract][Full Text] [Related]
9. Incidence of metachronous testicular cancer in patients with extragonadal germ cell tumors.
Hartmann JT; Fossa SD; Nichols CR; Droz JP; Horwich A; Gerl A; Beyer J; Pont J; Fizazi K; Hecker H; Kanz L; Einhorn L; Bokemeyer C
J Natl Cancer Inst; 2001 Nov; 93(22):1733-8. PubMed ID: 11717334
[TBL] [Abstract][Full Text] [Related]
10. Second malignancies among survivors of germ-cell testicular cancer: a pooled analysis between 13 cancer registries.
Richiardi L; Scélo G; Boffetta P; Hemminki K; Pukkala E; Olsen JH; Weiderpass E; Tracey E; Brewster DH; McBride ML; Kliewer EV; Tonita JM; Pompe-Kirn V; Kee-Seng C; Jonasson JG; Martos C; Brennan P
Int J Cancer; 2007 Feb; 120(3):623-31. PubMed ID: 17096341
[TBL] [Abstract][Full Text] [Related]
11. Nontesticular cancers in relatives of testicular germ cell tumor (TGCT) patients from multiple-case TGCT families.
McMaster ML; Heimdal KR; Loud JT; Bracci JS; Rosenberg PS; Greene MH
Cancer Med; 2015 Jul; 4(7):1069-78. PubMed ID: 25882629
[TBL] [Abstract][Full Text] [Related]
12. Bilateral testicular germ cell tumors in Turkey: increase in incidence in last decade and evaluation of risk factors in 30 patients.
Akdogan B; Divrik RT; Tombul T; Yazici S; Tasar C; Zorlu F; Ozen H
J Urol; 2007 Jul; 178(1):129-33; discussion 133. PubMed ID: 17499297
[TBL] [Abstract][Full Text] [Related]
13. Management and outcome of bilateral testicular germ cell tumors: a 25-year single center experience.
Klatte T; de Martino M; Arensmeier K; Reiher F; Allhoff EP; Klatte D
Int J Urol; 2008 Sep; 15(9):821-6. PubMed ID: 18657202
[TBL] [Abstract][Full Text] [Related]
14. Malignant ovarian germ cell tumors: presentation, survival and second cancer in a population based Norwegian cohort (1953-2009).
Solheim O; Kærn J; Tropé CG; Rokkones E; Dahl AA; Nesland JM; Fosså SD
Gynecol Oncol; 2013 Nov; 131(2):330-5. PubMed ID: 24001518
[TBL] [Abstract][Full Text] [Related]
15. Continuing increased risk of second cancer in long-term testicular cancer survivors after treatment in the cisplatin era.
Hellesnes R; Kvammen Ø; Myklebust TÅ; Bremnes RM; Karlsdottir Á; Negaard HFS; Tandstad T; Wilsgaard T; Fosså SD; Haugnes HS
Int J Cancer; 2020 Jul; 147(1):21-32. PubMed ID: 31597192
[TBL] [Abstract][Full Text] [Related]
16. Bilateral testicular germ cell tumors: twenty-year experience at M. D. Anderson Cancer Center.
Che M; Tamboli P; Ro JY; Park DS; Ro JS; Amato RJ; Ayala AG
Cancer; 2002 Sep; 95(6):1228-33. PubMed ID: 12216089
[TBL] [Abstract][Full Text] [Related]
17. Management and outcome of bilateral testicular germ cell tumors: Twenty-five year experience in Munich.
Hentrich M; Weber N; Bergsdorf T; Liedl B; Hartenstein R; Gerl A
Acta Oncol; 2005; 44(6):529-36. PubMed ID: 16165911
[TBL] [Abstract][Full Text] [Related]
18. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
19. Risk of bilateral testicular germ cell cancer in Denmark: 1960-1984.
Osterlind A; Berthelsen JG; Abildgaard N; Hansen SO; Hjalgrim H; Johansen B; Munck-Hansen J; Rasmussen LH
J Natl Cancer Inst; 1991 Oct; 83(19):1391-5. PubMed ID: 1656057
[TBL] [Abstract][Full Text] [Related]
20. Bilateral Testicular Germ Cell Tumors in the Era of Multimodal Therapy.
Kopp RP; Chevinsky M; Bernstein M; Bosl G; Motzer R; Bajorin D; Feldman D; Carver BS; Sheinfeld J
Urology; 2017 May; 103():154-160. PubMed ID: 27816603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
